A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...
Arkansas' first noninvasive treatment of early-stage prostate cancer was successfully performed at St. Bernards Medical Center, reducing risks and side effects.
A new urine test, MyProstateScore 2.0 (MPS2), can now detect aggressive prostate cancer with 94 per cent accuracy—no hospital visit required. This at-home test identifies high-risk cases, reducing ...